Last reviewed · How we verify

NCT07124767

The Effects Of Low Insulinemic Index Diet On Overweight And Obese Patients With Polycystic Ovary Syndrome

Completed NA Last updated 15 August 2025
What this trial tests

NA trial testing 6 weeks of diet with low insulin index diet in PCOS (Polycystic Ovary Syndrome) in 30 participants. Completed in 22 July 2025.

Timeline
28 June 2024
Primary endpoint
20 May 2025
22 July 2025

Quick facts

Lead sponsorBetül Gümüş
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment30
Start date28 June 2024
Primary completion20 May 2025
Estimated completion22 July 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Betül Gümüş

Who can join

Adults 18 to 45, female only, with PCOS (Polycystic Ovary Syndrome) or Insulinemic Response. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to investigate the relationship between PCOS and insulinemic index in overweight and/or obese women with PCOS and to evaluate potential beneficial effects on PCOS. In this study, overweight and obese women with PCOS were divided into two groups. The first group (n=15) received a 6-week nutritional program consisting of low insulin index foods as recommended by TÜBER, while the other group (n=15) received the healthy eating recommendations outlined in TÜBER. Differences in endocrine, metabolic, and anthropometric parameters between these two groups were examined after each 6-week dietary intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for PCOS (Polycystic Ovary Syndrome)

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07124767.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing